Andrew Mettry

Cooley advised Rubicon Technology Partners – a Boulder, Colorado-based private equity firm focused exclusively on investing in and growing software companies – on its majority strategic investment in Vimly Benefit Solutions, a leader in the benefits administration space.

Cooley advised COUR Pharmaceuticals, a clinical-stage biotechnology company focused on the development of first-in-class disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, on the close of its $105 million Series A financing.

Cooley advised CallTower, an international leader in delivering cloud-based, enterprise-class communications, contact center and collaboration solutions, on its investment from BV Investment Partners.

Cooley advised MindMed, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, on its successful proxy contest against FCM MM Holdings.

Cooley advised Momofuku Goods, a brand of restaurant-grade pantry staples, on its $17.5 million Series A financing led by Siddhi Capital. The new funding will allow Momofuku to expand product offerings and support its growing operations, which includes scaling its team and marketing efforts.

“We spent a decade testing and developing our pantry essentials, ensuring that they were up to the standards we uphold in our restaurants,” David Chang, celebrity chef and founder of Momofuku restaurant group, said in a press statement. “With this investment, I’m looking forward to bringing even more flavor to home cooks’ kitchens.” Founded by the team behind Momofuku restaurants, Momofuku Goods offers a range of products, including chili crunch oil, air-dried noodles, soy sauce, rice vinegar and seasoned salts that are sold online and in more than 2,000 retail stores.

Winston Gu and Yvan-Claude Pierre led the Cooley team, which also included Len Jacoby, JP Oleksiuk, Jonathan Rivinus, Robert Eisenbach, Joyce Kim, Chris Chynoweth, Andrew Mettry, Bomin Kim and Noah Belsky.